Significantly higher tumor TfR1 levels were also detected in patients with a lower BMI, smoking history and anemia (particularly iron-deficient anemia and patients on iron supplementation), all clinical features associated with worse RCC patient outcomes [61-64]. This evidence concerns the gene TFRC and Iron deficiency anemia.